NVO logo

Novo Nordisk A/S (NVO) Total Assets

Annual Total Assets

$64.99 B
+$18.29 B+39.18%

December 31, 2024


Summary


Performance

NVO Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVObalance sheetmetrics:

Quarterly Total Assets

$64.99 B
+$5.46 B+9.17%

December 31, 2024


Summary


Performance

NVO Quarterly Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVObalance sheetmetrics:

Total Assets Formula

Total Assets = Current Assets + Non-Current Assets

NVO Total Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+39.2%+22.6%
3 y3 years+119.5%+119.5%
5 y5 years+245.1%+245.1%

NVO Total Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+119.5%at high+119.7%
5 y5-yearat high+245.1%at high+248.5%
alltimeall timeat high>+9999.0%at high>+9999.0%

Novo Nordisk A/S Total Assets History

DateAnnualQuarterly
Dec 2024
$64.99 B(+39.2%)
$64.99 B(+9.2%)
Sep 2024
-
$59.53 B(+12.3%)
Jun 2024
-
$53.03 B(+22.6%)
Mar 2024
-
$43.24 B(-7.4%)
Dec 2023
$46.69 B(+34.5%)
$46.69 B(+9.9%)
Sep 2023
-
$42.50 B(+3.7%)
Jun 2023
-
$40.97 B(+11.9%)
Mar 2023
-
$36.60 B(+5.4%)
Dec 2022
$34.72 B(+17.3%)
$34.72 B(+8.2%)
Sep 2022
-
$32.10 B(+4.4%)
Jun 2022
-
$30.74 B(+3.9%)
Mar 2022
-
$29.58 B(-0.1%)
Dec 2021
$29.61 B(+23.6%)
$29.61 B(+9.0%)
Sep 2021
-
$27.16 B(+7.3%)
Jun 2021
-
$25.30 B(+13.5%)
Mar 2021
-
$22.29 B(-7.0%)
Dec 2020
$23.95 B(+27.2%)
$23.95 B(+8.6%)
Sep 2020
-
$22.07 B(+7.5%)
Jun 2020
-
$20.53 B(+10.1%)
Mar 2020
-
$18.65 B(-1.0%)
Dec 2019
$18.83 B(+11.0%)
$18.83 B(+2.9%)
Sep 2019
-
$18.30 B(+1.9%)
Jun 2019
-
$17.96 B(+8.5%)
Mar 2019
-
$16.55 B(-2.5%)
Dec 2018
$16.97 B(+2.9%)
$16.97 B(+7.0%)
Sep 2018
-
$15.85 B(-1.0%)
Jun 2018
-
$16.02 B(+3.5%)
Mar 2018
-
$15.47 B(-6.2%)
Dec 2017
$16.49 B(+18.9%)
$16.49 B(+6.5%)
Sep 2017
-
$15.49 B(+3.0%)
Jun 2017
-
$15.05 B(+11.2%)
Mar 2017
-
$13.53 B(-2.4%)
Dec 2016
$13.87 B(+3.2%)
$13.87 B(+5.5%)
Sep 2016
-
$13.14 B(-0.4%)
Jun 2016
-
$13.20 B(+5.4%)
Mar 2016
-
$12.52 B(-6.9%)
Dec 2015
$13.45 B(+6.9%)
$13.45 B(+4.6%)
Sep 2015
-
$12.85 B(+5.1%)
Jun 2015
-
$12.22 B(+8.9%)
Mar 2015
-
$11.23 B(-10.8%)
Dec 2014
$12.58 B(-3.4%)
$12.58 B(+3.5%)
Sep 2014
-
$12.15 B(+4.3%)
Jun 2014
-
$11.65 B(+0.1%)
Mar 2014
-
$11.64 B(-10.6%)
Dec 2013
$13.02 B(+11.9%)
$13.02 B(+5.6%)
Sep 2013
-
$12.33 B(+9.7%)
Jun 2013
-
$11.23 B(+4.7%)
Mar 2013
-
$10.73 B(-7.8%)
Dec 2012
$11.64 B(+3.2%)
$11.64 B(+0.9%)
Sep 2012
-
$11.54 B(+13.0%)
Jun 2012
-
$10.21 B(-6.8%)
Mar 2012
-
$10.95 B(-2.8%)
DateAnnualQuarterly
Dec 2011
$11.27 B(+2.9%)
$11.27 B(-0.4%)
Sep 2011
-
$11.32 B(-5.2%)
Jun 2011
-
$11.94 B(+6.9%)
Mar 2011
-
$11.17 B(+2.0%)
Dec 2010
$10.95 B(+4.0%)
$10.95 B(+4.8%)
Sep 2010
-
$10.45 B(+11.6%)
Jun 2010
-
$9.36 B(-4.7%)
Mar 2010
-
$9.82 B(-6.7%)
Dec 2009
$10.53 B(+10.6%)
$10.53 B(+1.8%)
Sep 2009
-
$10.35 B(+7.1%)
Jun 2009
-
$9.66 B(+8.2%)
Mar 2009
-
$8.92 B(-6.2%)
Dec 2008
$9.52 B(+1.8%)
$9.52 B(+3.0%)
Sep 2008
-
$9.25 B(-9.7%)
Jun 2008
-
$10.24 B(+2.1%)
Mar 2008
-
$10.03 B(+7.3%)
Dec 2007
$9.35 B(+18.2%)
$9.35 B(+0.9%)
Sep 2007
-
$9.26 B(+5.4%)
Jun 2007
-
$8.79 B(+9.6%)
Mar 2007
-
$8.02 B(+1.4%)
Dec 2006
$7.91 B(+19.0%)
$7.91 B(+6.2%)
Sep 2006
-
$7.44 B(+0.7%)
Jun 2006
-
$7.39 B(+10.2%)
Mar 2006
-
$6.70 B(+0.9%)
Dec 2005
$6.65 B(-3.2%)
$6.65 B(+2.7%)
Sep 2005
-
$6.47 B(+5.9%)
Jun 2005
-
$6.11 B(-3.9%)
Mar 2005
-
$6.36 B(-7.4%)
Dec 2004
$6.86 B(+17.6%)
$6.86 B(+15.5%)
Sep 2004
-
$5.94 B(+5.8%)
Jun 2004
-
$5.61 B(+1.0%)
Mar 2004
-
$5.56 B(-4.7%)
Dec 2003
$5.83 B(+31.4%)
$5.83 B(+31.4%)
Dec 2002
$4.44 B(+30.0%)
$4.44 B(+30.0%)
Dec 2001
$3.42 B(+11.4%)
$3.42 B(+11.4%)
Dec 2000
$3.07 B(-1.7%)
$3.07 B(-1.7%)
Dec 1999
$3.12 B(-27.2%)
$3.12 B(-27.2%)
Dec 1998
$4.28 B(+13.7%)
$4.28 B(+13.7%)
Dec 1997
$3.77 B(+0.5%)
$3.77 B(+0.5%)
Dec 1996
$3.75 B(+3.3%)
$3.75 B(+3.3%)
Dec 1995
$3.63 B(+4.5%)
$3.63 B(+4.5%)
Dec 1994
$3.47 B(+22.2%)
$3.47 B(+22.2%)
Dec 1993
$2.84 B(+6.0%)
$2.84 B(+6.0%)
Dec 1992
$2.68 B(+3.8%)
$2.68 B(+3.8%)
Dec 1991
$2.58 B(+19.5%)
$2.58 B(+19.5%)
Dec 1990
$2.16 B(+22.6%)
$2.16 B(+22.6%)
Dec 1989
$1.76 B(+31.5%)
$1.76 B(+31.5%)
Dec 1988
$1.34 B(-1.0%)
$1.34 B(-1.0%)
Dec 1987
$1.35 B(+22.2%)
$1.35 B(+22.2%)
Dec 1986
$1.11 B(+35.1%)
$1.11 B(+35.1%)
Dec 1985
$820.77 M(+32.5%)
$820.77 M(+32.5%)
Dec 1984
$619.33 M
$619.33 M

FAQ

  • What is Novo Nordisk A/S annual total assets?
  • What is the all time high annual total assets for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual total assets year-on-year change?
  • What is Novo Nordisk A/S quarterly total assets?
  • What is the all time high quarterly total assets for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly total assets year-on-year change?

What is Novo Nordisk A/S annual total assets?

The current annual total assets of NVO is $64.99 B

What is the all time high annual total assets for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual total assets is $64.99 B

What is Novo Nordisk A/S annual total assets year-on-year change?

Over the past year, NVO annual total assets has changed by +$18.29 B (+39.18%)

What is Novo Nordisk A/S quarterly total assets?

The current quarterly total assets of NVO is $64.99 B

What is the all time high quarterly total assets for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly total assets is $64.99 B

What is Novo Nordisk A/S quarterly total assets year-on-year change?

Over the past year, NVO quarterly total assets has changed by +$11.96 B (+22.56%)